🔎 Trials Near Me

Hjem › Myeloproliferative neoplasmer › North Carolina

Kliniske studier for Myeloproliferative neoplasmer i North Carolina

13 studier for Myeloproliferative neoplasmer søker deltakere på steder i North Carolina.

Byer i North Carolina

Offisiell studietekst (engelsk)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Novant Health Presbyterian Medical Center, Charlotte
  • og 5 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564390

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Atrium Health Cabarrus/LCI-Concord, Concord
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06661915

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Atrium Health Wake Forest Baptist, Winston-Salem
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Duke University Medical Center, Durham
  • East Carolina University, Greenville
  • og 1 flere
RekruttererFase 2
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

Project: Every Child for Younger Patients With Cancer

  • Mission Hospital, Asheville
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • og 4 flere
RekruttererObservasjonsstudie
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • University of North Carolina At Chapel Hill, Chapel Hill
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • University of North Carolina At Chapel Hill, Chapel Hill
  • Levine Cancer Institute, Charlotte
  • Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07441694

Evaluation of the Pathobiology of CALR-mutated MPN Cells

  • Atrium Health Levine Cancer, Charlotte
  • Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 13. jul. 2026 · NCT06480591

Registry of Older Patients With Cancer

  • Seby B. Jones Cancer Center, Boone
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
  • East Carolina University, Greenville
  • og 4 flere
RekruttererObservasjonsstudie
Alder 65 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT01137825

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • Wake Forest Baptist Medical Center, Winston-Salem
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 17. apr. 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 27. okt. 2025 · NCT01137643

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.